Vitamin D Analogs Versus Native Vitamin D in Preventing Bone Loss and Osteoporosis-Related Fractures: A Comparative Meta-analysis
The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Abstract
It has been suggested that early postmenopausal women and patients treated with steroids should receive preventive therapy (calcium, vitamin D, vitamin D analogs, estrogens, or bisphosphonates) to preserve their bone mineral density (BMD) and to avoid fragility fractures. We designed the present study to compare the effects of native vitamin D to its hydroxylated analogs alfacalcidol 1-alpha(OH)D and calcitriol 1,25(OH)(2)D. All randomized, controlled, double-blinded trials comparing oral native vitamin D and its analogs, alfacalcidol or calcitriol, to placebo or head-to-head trials in primary or corticosteroids-induced osteoporosis were included in the meta-analysis. Sources included the Cochrane Controlled Trials Register, EMBASE, MEDLINE, and a hand search of abstracts and references lists. The study period January 1985 to January 2003. Data were abstracted by two investigators, and methodological quality was assessed in a similar manner. Heterogeneity was extensively investigated. Results were expressed as effect-size (ES) for bone loss and as rate difference (RD) for fracture while allocated to active treatment or control. Publication bias was investigated. Fourteen studies of native vitamin D, nine of alfacalcidol, and ten of calcitriol fit the inclusion criteria. The two vitamin D analogs appeared to exert a higher preventive effect on bone loss and fracture rates in patients not exposed to glucocorticoids. With respect to BMD, vitamin D analogs versus placebo studies…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For four meta-analyses, it was unclear if omission of the affected trial reports would alter the findings (Richy et al 25 79 citations, October 2018; Richy et al 26 91 citations, February 2018; Murad et al 27 26 citations, August 2018; Yang et al 28 54 citations, October 2018).”
From An investigation into the impact and implications of published papers from retracted research: systematic search of affected literature (2019) · cites this paper as [26]
Citations
Cites
2 retracted
Sato, Y., Manabe, S., Kuno, H., & Oizumi, K. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.1.64 · Cited by 131
RetractedSato, Y., Maruoka, H., & Oizumi, K. (1997) · Stroke · doi:10.1161/01.str.28.4.736 · Cited by 76
RetractedBias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Dawson-Hughes, B., Harris, S. S., Krall, E. A., & Dallal, G. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371003 · Cited by 2,277
Systematic Reviews: Identifying relevant studies for systematic reviews
Dickersin, K., Scherer, R., & Lefebvre, C. (1994) · BMJ · doi:10.1136/bmj.309.6964.1286 · Cited by 2,256
Bucher, H. C., Guyatt, G. H., Griffith, L. E., & Walter, S. D. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00049-8 · Cited by 2,052
Trivedi, D. P., Doll, R., & Khaw, K. T. (2003) · BMJ · doi:10.1136/bmj.326.7387.469 · Cited by 1,270
Song, F., Altman, D. G., Glenny, A.-M., & Deeks, J. J. (2003) · BMJ · doi:10.1136/bmj.326.7387.472 · Cited by 943
Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women
Chapuy, M. C., Arlot, M. E., Delmans, P. D., & Meunier, P. J. (1994) · BMJ · doi:10.1136/bmj.308.6936.1081 · Cited by 673
Avenell, A., Gillespie, W. J., Gillespie, L. D., & O'Connell, D. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000227.pub3 · Cited by 667
Lips, P., Graafmans, W. C., Ooms, M. E., Bezemer, P. D., & Bouter, L. M. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-4-199602150-00003 · Cited by 646
IX: Summary of Meta-Analyses of Therapies for Postmenopausal Osteoporosis
Cranney, A., Guyatt, G., Griffith, L., Wells, G., Tugwell, P., Rosen, C., The Osteoporosis Methodology Group, & The Osteoporosis Research Advisory Group (2002) · Endocrine Reviews · doi:10.1210/er.2001-9002 · Cited by 604
Pfeifer, M., Begerow, B., Minne, H. W., Abrams, C., Nachtigall, D., & Hansen, C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.1113 · Cited by 591
Treatment of Postmenopausal Osteoporosis with Calcitriol or Calcium
Tilyard, M. W., Spears, G. F. S., Thomson, J., & Dovey, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202063260601 · Cited by 575
Prevention of Corticosteroid Osteoporosis -- A Comparison of Calcium, Calcitriol, and Calcitonin
Sambrook, P., Birmingham, J., Kelly, P., Kempler, S., Nguyen, T., Pocock, N., & Eisman, J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282404 · Cited by 520
Dawson-Hughes, B., Dallal, G. E., Krall, E. A., Harris, S., Sokoll, L. J., & Falconer, G. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-7-505 · Cited by 500
Ooms, M. E. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.4.1052 · Cited by 486
Tsai, K. S., Heath, H., Kumar, R., & Riggs, B. L. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111373 · Cited by 362
Buckley, L. M., Leib, E. S., Cartularo, K. S., Vacek, P. M., & Cooper, S. M. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-12-199612150-00004 · Cited by 310
Papadimitropoulos, E., Wells, G., Shea, B., Gillespie, W., Weaver, B., Zytaruk, N., Cranney, A., Adachi, J., Tugwell, P., Josse, R., et al. (2002) · Endocrine Reviews · doi:10.1210/er.2001-8002 · Cited by 302
Komulainen, M. H., Kröger, H., Tuppurainen, M. T., Heikkinen, A.-M., Alhava, E., Honkanen, R., & Saarikoski, S. (1998) · Maturitas · doi:10.1016/s0378-5122(98)00085-1 · Cited by 235
Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup.
Adachi, J. D., Wg, B., Bianchi, F. A., Cividino, A. A., Pillersdorf, S., Sebaldt, R. J., Tugwell, P., Gordon, M., Steele, M., Webber, C., et al. (1996) · PubMed · Cited by 234
Meyer, H. E., Smedshaug, G. B., Kvaavik, E., Falch, J. A., Tverdal, A., & Pedersen, J. I. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.4.709 · Cited by 226
Orimo, H., Shiraki, M., Hayashi, Y., Hoshino, T., Onaya, T., Miyazaki, S., Kurosawa, H., Nakamura, T., & Ogawa, N. (1994) · Calcified Tissue International · doi:10.1007/bf00305521 · Cited by 222
Calcitriol in the treatment of postmenopausal osteoporosis
Aloia, J. F., Vaswani, A., Yeh, J. K., Ellis, K., Yasumura, S., & Cohn, S. H. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90259-8 · Cited by 218
Gallagher, J. C., & Goldgar, D. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-9-649 · Cited by 217
Combination Treatment with Estrogen and Calcitriol in the Prevention of Age-Related Bone Loss
Gallagher, J. C., Fowler, S. E., Detter, J. R., & Sherman, S. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7703 · Cited by 216
BERNSTEIN, C. N., SEEGER, L. L., ANTON, P. A., ARTINIAN, L., GEFFREY, S., GOODMAN, W., BELIN, T. R., & SHANAHAN, F. (1996) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1996.63205000.x · Cited by 146
Sambrook, P. N., Kotowicz, M., Nash, P., Styles, C. B., Naganathan, V., Henderson-Briffa, K. N., Eisman, J. A., & Nicholson, G. C. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.5.919 · Cited by 142
A comprehensive review of treatments for postmenopausal osteoporosis
Häuselmann, H. J., & Rizzoli, R. (2003) · Osteoporosis International · doi:10.1007/s00198-002-1301-3 · Cited by 131
Pattanaungkul, S., Riggs, B. L., Yergey, A. L., Vieira, N. E., O’Fallon, W. M., & Khosla, S. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6938 · Cited by 129
Calcium and Vitamin D Supplementation Increases Spinal BMD in Healthy, Postmenopausal Women
Bæksgaard, L., Andersen, K. P., & Hyldstrup, L. (1998) · Osteoporosis International · doi:10.1007/s001980050062 · Cited by 127
Gallagher, J. C., Riggs, B. L., Recker, R. R., & Goldgar, D. (1989) · Experimental Biology and Medicine · doi:10.3181/00379727-191-42922 · Cited by 119
Effect of Calcitriol on Bone Loss After Cardiac or Lung Transplantation
Sambrook, P., Henderson, N. K., Keogh, A., MacDonald, P., Glanville, A., Spratt, P., Bergin, P., Ebeling, P., & Eisman, J. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.9.1818 · Cited by 119
Komulainen, M., Kröger, H., Tuppurainen, M. T., Heikkinen, A.-M., Alhava, E., Honkanen, R., Jurvelin, J., & Saarikoski, S. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5496 · Cited by 100
Hunter, D., Major, P., Arden, N., Swaminathan, R., Andrew, T., MacGregor, A. J., Keen, R., Snieder, H., & Spector, T. D. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.11.2276 · Cited by 90
SHIRAKI, M., KUSHIDA, K., YAMAZAKI, K., NAGAI, T., INOUE, T., & ORIMO, H. (1996) · Endocrine Journal · doi:10.1507/endocrj.43.211 · Cited by 79
Stempfle, H.-U., Werner, C., Echtler, S., Wehr, U., Rambeck, W. A., Siebert, U., ??derfuhr, P., Angermann, C. E., Theisen, K., & G??rtner, R. (1999) · Transplantation · doi:10.1097/00007890-199908270-00014 · Cited by 78
Ebeling, P. R., Wark, J. D., Yeung, S., Poon, C., Salehi, N. S., Nicholson, G. C., & Kotowicz, M. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4098 · Cited by 74
Lau, K. ‐. W., & Baylink, D. J. (1999) · Calcified Tissue International · doi:10.1007/s002239900702 · Cited by 73
Prevention of corticosteroid-induced osteoporosis by alfacalcidol
Lakatos, P. L., Nagy, Z., Kiss, L., Horváth, C., Takács, I., Földes, J., Speer, G., & Bossányi, A. (2000) · Zeitschrift für Rheumatologie · doi:10.1007/s003930070040 · Cited by 52
Decrease of vertebral fracture in osteoporotics by administration of 1α-hydroxy-vitamin D3
Hayashi, Y., Fujita, T., & Inoue, T. (1992) · Journal of Bone and Mineral Metabolism · doi:10.1007/bf02378983 · Cited by 46
Alfacalcidol (Alpha D3) and Calcium in Osteoporosis
MENCZEL, J., FOLDES, J., STEINBERG, R., LEICHTER, I., SHALITA, B., BDOLAH-ABRAM, T., KADOSH, S., MAZOR, Z., & LADKANI, D. (1994) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199403000-00033 · Cited by 45
Scopacasa, F., Wishart, J. M., Horowitz, M., Morris, H. A., & Need, A. G. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601777 · Cited by 34
Lambrinoudaki, I. V., Chan, T. M., Lau, C. S., Wong, R. W., Yeung, S. S., & Kung, A. W. C. (2000) · PubMed · Cited by 32
Efficacy of ipriflavone and 1α vitamin D therapy for the cessation of vertebral bone loss
Ushiroyama, T., Okamura, S., Ikeda, A., & Ueki, M. (1995) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(94)02280-c · Cited by 30
Treatment of Postmenopausal Osteoporosis with Calcitriol or Calcium
Tilyard, M., Gf, S., Thomson, J., Dovey, S. L., & Schlechte, J. (1992) · The Endocrinologist · doi:10.1097/00019616-199207000-00016 · Cited by 28
Ringe, J. D. (2004) · Rheumatology International · doi:10.1007/s00296-004-0523-4 · Cited by 17
Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis
Reginster, J., Kuntz, D., Verdickt, W., Wouters, M., Guillevin, L., Menkes, C. J., & Rawlinson, D. (1997) · ORBi (University of Liège) · Cited by 5
Self-citationCruz-Hofling, M. A., Freitas, I., Baranauskas, V, Joazeiro, P. P., & Pai-Silva, M. D. (2003) · Bone · doi:10.1016/s8756-3282(03)00122-4 · Cited by 3
Vitamin D with or without calcium for treating osteoporosis in postmenopausal women
Papadimitropoulos, E., Shea, B., Wells, G. A., Tugwell, P., Cranney, A., Gillespie, W. J., Josse, R. G., Coyte, P. C., & Greenwood (1997) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000519 · Cited by 2
Research works printed but not linked: 10
- WJ Gillespie, 2001, Cochrane Database Syst Rev, 1, CD000227
- E Papadimitropoulos, 2002, Cochrane Database Syst Rev, ., .
- S Pattanaungkul, 2000, J Clin Endocrinol Metab, 85, 4023
- M Komulainen, 1999, J Clin Endocrinol Metab, 84, 546
- ME Ooms, 1995, J Clin Endocrinol Metab, 80, 1052
- JD Adachi, 1996, J Rheum, 23, 995
- Y Hayashi, 1992, J Bone Min Res, 10, 184
- JY Reginster, 1999, Bone, 9, 75
- PR Ebeling, 2001, J Clin Endocr Metab, 86, 4096, 10.1210/jcem.86.9.7847 · doi:10.1210/jcem.86.9.7847 · Paper page
- I Lambrinoudaki, 2000, J Rheumatol, 27, 1759
Cited by
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Kanis, J. A., McCloskey, E. V., Johansson, H., Cooper, C., Rizzoli, R., Reginster, J.-Y., & on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) · Osteoporosis International · doi:10.1007/s00198-012-2074-y · Cited by 2,948
Self-citationEuropean guidance for the diagnosis and management of osteoporosis in postmenopausal women
on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF), Kanis, J. A., Cooper, C., Rizzoli, R., & Reginster, J.-Y. (2019) · Osteoporosis International · doi:10.1007/s00198-018-4704-5 · Cited by 1,900
Self-citationEuropean guidance for the diagnosis and management of osteoporosis in postmenopausal women
Kanis, J. A., Burlet, N., Cooper, C., Delmas, P. D., Reginster, J.-Y., Borgstrom, F., Rizzoli, R., & on behalf of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) (2008) · Osteoporosis International · doi:10.1007/s00198-008-0560-z · Cited by 776
Self-citationVitamin D supplementation for prevention of mortality in adults
Bjelakovic, G., Gluud, L. L., Nikolova, D., Whitfield, K., Wetterslev, J., Simonetti, R. G., Bjelakovic, M., & Gluud, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007470.pub3 · Cited by 695
Qaseem, A., Forciea, M. A., McLean, R. M., Denberg, T. D., & for the Clinical Guidelines Committee of the American College of Physicians* (2017) · Annals of Internal Medicine · doi:10.7326/m15-1361 · Cited by 676
Metadata
- Authors
- Richy, F., Schacht, E., Bruyere, O., Ethgen, O., Gourlay, M., & Reginster, J.-Y.
- Affiliations
- University of Liège (BE)
- Universitätsklinik Balgrist (CH)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Richy, F.
- Venue
- Calcified Tissue International
- Published
- 2005-02-07
- Volume
- 76
- Issue
- 3
- Pages
- 176-186
- ISSN
- 0171-967X (ISSN-L)
- 1432-0827
- OpenAlex
- W1990973570
- Cited by
- 137
- References
- 53
- Citations by year
- 2024: 1 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 4 · 2019: 5 · 2018: 3 · 2017: 6 · 2016: 5 · 2015: 10 · 2014: 5 · 2013: 8 · 2012: 2
- FWCI
- 13.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Calcified Tissue International (publishedVersion)
- PubMed (publishedVersion)
- ORBi (University of Liège) (submittedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin K Research Studies
- Keywords
- vitamin D analogs, alfacalcidol, 1,25-dihydroxyvitamin D3, postmenopausal osteoporosis, glucocorticoid-induced osteoporosis, bone mineral density, fragility fractures, fracture prevention, bone loss, lumbar spine bone mineral density, vitamin D receptor agonists, bisphosphonates, estrogen therapy, calcium supplementation, osteoporosis
- MeSH terms
- Adrenal Cortex Hormones, Calcitriol, Female, Humans, Hydroxycholecalciferols, Male, Middle Aged, Osteoporosis, Vitamin D, Bone Density, Treatment Outcome, Fractures, Bone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.